Law firm investigates Treace Medical over stock drop after revenue and outlook cut.

Johnson Fistel, PLLP is investigating claims on behalf of Treace Medical Concepts investors after the company reported weaker-than-expected Q3 2025 results and lowered its full-year revenue guidance. Treace cited lower demand for its Lapiplasty System due to changing surgeon preferences and economic factors affecting elective surgeries. The stock price fell sharply following these disclosures, prompting the investigation into possible securities law violations. Investors who suffered losses are encouraged to contact Johnson Fistel for potential recovery options.